Biotavia Labs Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
as on 24-10-2024
- Paid Up Capital ₹ 2.56 Cr
as on 24-10-2024
- Company Age 18 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 24.14 Cr
as on 24-10-2024
- Satisfied Charges ₹ 1.50 Cr
as on 24-10-2024
- Revenue 21.12%
(FY 2023)
- Profit -71.62%
(FY 2023)
- Ebitda -152.41%
(FY 2023)
- Net Worth 5.81%
(FY 2023)
- Total Assets -2.04%
(FY 2023)
About Biotavia Labs
The Corporate was formerly known as Actavia Labs Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 2.56 Cr.
The company currently has active open charges totaling ₹24.14 Cr. The company has closed loans amounting to ₹1.50 Cr, as per Ministry of Corporate Affairs (MCA) records.
Vipul Goel and Sameer Goel serve as directors at the Company.
- CIN/LLPIN
U85121DL2006PTC154528
- Company No.
154528
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Sep 2006
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Biotavia Labs?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sameer Goel  | Director | 15-Jun-2021 | Current |
| Vipul Goel | Director | 10-Apr-2009 | Current |
Financial Performance of Biotavia Labs.
Biotavia Labs Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 21.12% increase. The company also saw a substantial fall in profitability, with a 71.62% decrease in profit. The company's net worth moved up by a moderate rise of 5.81%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Biotavia Labs?
In 2023, Biotavia Labs had a promoter holding of 100.00%. The company had 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Zeneses Biosciences Private LimitedActive 21 years 18 days
Vipul Goel and Sameer Goel are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 12 Apr 2023 | ₹24.14 Cr | Open |
Hdfc Bank Limited Creation Date: 21 Dec 2011 | ₹0.04 M | Satisfied |
Icici Bank Limited Creation Date: 11 Aug 2007 | ₹1.50 Cr | Satisfied |
How Many Employees Work at Biotavia Labs?
Biotavia Labs has a workforce of 5 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Biotavia Labs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Biotavia Labs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
